Christopher Leland Herold - Publications

2002 University of North Carolina, Chapel Hill, Chapel Hill, NC 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Johns DG, Ao Z, Naselsky D, Herold CL, Maniscalco K, Sarov-Blat L, Steplewski K, Aiyar N, Douglas SA. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Naunyn-Schmiedeberg's Archives of Pharmacology. 370: 238-50. PMID 15549273 DOI: 10.1007/s00210-004-0980-z  0.52
2004 Douglas SA, Naselsky D, Ao Z, Disa J, Herold CL, Lynch F, Aiyar NV. Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines. British Journal of Pharmacology. 142: 921-32. PMID 15210573 DOI: 10.1038/sj.bjp.0705743  0.52
2004 Behm DJ, Herold CL, Camarda V, Aiyar NV, Douglas SA. Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors. European Journal of Pharmacology. 492: 113-6. PMID 15178353 DOI: 10.1016/j.ejphar.2004.03.059  0.52
2004 Herold CL, Qi AD, Harden TK, Nicholas RA. Agonist versus antagonist action of ATP at the P2Y4 receptor is determined by the second extracellular loop. The Journal of Biological Chemistry. 279: 11456-64. PMID 14670966 DOI: 10.1074/jbc.M301734200  0.52
2003 Herold CL, Behm DJ, Buckley PT, Foley JJ, Wixted WE, Sarau HM, Douglas SA. The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors. British Journal of Pharmacology. 139: 203-7. PMID 12770925 DOI: 10.1038/sj.bjp.0705251  0.52
2002 Behm DJ, Herold CL, Ohlstein EH, Knight SD, Dhanak D, Douglas SA. Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist. British Journal of Pharmacology. 137: 449-58. PMID 12359626 DOI: 10.1038/sj.bjp.0704887  0.52
2000 Kennedy C, Qi AD, Herold CL, Harden TK, Nicholas RA. ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor. Molecular Pharmacology. 57: 926-31. PMID 10779375  0.52
1997 Herzyk DJ, Ruggieri EV, Cunningham L, Polsky R, Herold C, Klinkner AM, Badger A, Kerns WD, Bugelski PJ. Single-organism model of host defense against infection: A novel immunotoxicologic approach to evaluate immunomodulatory drugs Toxicologic Pathology. 25: 351-362. PMID 9280118  0.52
1997 Herold CL, Li Q, Schachter JB, Harden TK, Nicholas RA. Lack of nucleotide-promoted second messenger signaling responses in 1321N1 cells expressing the proposed P2Y receptor, p2y7. Biochemical and Biophysical Research Communications. 235: 717-21. PMID 9207227 DOI: 10.1006/bbrc.1997.6884  0.52
1994 Ichiki T, Herold CL, Kambayashi Y, Bardhan S, Inagami T. Cloning of the cDNA and the genomic DNA of the mouse angiotensin II type 2 receptor. Biochimica Et Biophysica Acta. 1189: 247-50. PMID 8292631 DOI: 10.1016/0005-2736(94)90072-8  0.52
Show low-probability matches.